The Effect of Foeniculum Vulgare Ironing on Gastrointestinal Recovery After Colorectal Resection

Sponsor
West China Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03711487
Collaborator
(none)
300
1
2
8.8
34.1

Study Details

Study Description

Brief Summary

Chinese Medicine Ironing using Foeniculum vulgare has been applied in some departments to promote bowel function recovery, but the efficacy of ironing therapy remains uncertain after colorectal resection surgery.

Condition or Disease Intervention/Treatment Phase
  • Drug: Foeniculum Vulgare Seed Ironing
Phase 2

Detailed Description

Postoperative ileus is one of the most common complications after abdominal surgery. It refers to obstipation and intolerance of oral intake due to nonmechanical factors that disrupt the normal coordinated propulsive motor activity of the gastrointestinal tract following abdominal or nonabdominal surgery. When the expected period of gastrointestinal recovery time extends beyond what is acceptable, the patient is diagnosed as having a "pathologic" postoperative ileus (POI), which leads to patient discomfort, dissatisfaction, prolonged hospitalization and increased medical expenses. The incidence of POI is about 17%~24% after abdominal surgery. Chinese Medicine Ironing using Foeniculum vulgare has been applied in some departments to promote gastrointestinal function recovery as a empiric therapy. However, the definite efficacy of Foeniculum vulgare ironing therapy(FIT)is uncertain after colorectal resection surgery and whether FIT can reduce the incidence of POI remains unkonown.

Study Design

Study Type:
Interventional
Actual Enrollment :
300 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
The Effect of Foeniculum Vulgare Ironing on Gastrointestinal Recovery After Colorectal Resection: a Randomized Controlled Trial.
Actual Study Start Date :
Oct 20, 2018
Actual Primary Completion Date :
Jun 15, 2019
Actual Study Completion Date :
Jul 15, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Ironing therapy

Stir-fry 500 grams of Foeniculum vulgare seeds until the aroma overflows. Put them into a cotton bag. Ironing therapy put the bag on abdomen after the temperature is suitable, 30 minutes per time, 4 times daily from 12 hours after surgery and last for 2 days. The medicine bag can be heated and reused after it cool down.

Drug: Foeniculum Vulgare Seed Ironing
Stir-fry 500 grams of Foeniculum vulgare seeds until the aroma overflows. Put them into a cotton bag. Ironing therapy put the bag on abdomen after the temperature is suitable, 30 minutes per time, twice daily on postoperative days 2 to 3. The medicine bag can be heated and reused after it cool down.

No Intervention: No intervention

No intervention.

Outcome Measures

Primary Outcome Measures

  1. Flatus time [Up to 30 days after operation.]

    Time to faltus (hours from end of operation). Patients who had stool before any movement of gas were deemed to have an equal time to the time to flatus and first bowel movement.

  2. Incidence of postoperative ileus [4 days after operation]

    The same panel defined "prolonged" postoperative ileus as the occurrence of two or more of the following signs and symptoms on postoperative day 4 or after: Nausea or vomiting, Inability to tolerate an oral diet over the preceding 24 hours, Absence of flatus over the preceding 24 hours, Abdominal distention.

Secondary Outcome Measures

  1. Toleration of a low-residue diet [Up to 30 days after operation.]

    Time (hours from end of operation) to tolerate a low-residue diet, defined as consuming >50% of the meal without emesis for 24 hours (time recorded was the time when the patient ate >50% of the meal).

  2. Toleration of drinking water [Up to 30 days after operation.]

    Time (hours from end of operation) to toleration of water.

  3. Duration of postoperative hospitalization [Up to 30 days after operation.]

    Postoperative days the patient was ready for hospital discharge based on Gastrointestinal function alone.

  4. Pain assessment [During postoperative hospitalization, up to 30 days after operation.]

    Assess postoperative pain with the pain visual analogue scale. Rate the pain levels on a likert scale from 0 (no pain) to 10 (pain as bad as it could possibly be).

  5. Nausea and appetite assessment [During postoperative hospitalization, up to 30 days after operation.]

    Rate their appetite and nausea levels on a likert scale from 0 (no appetite, nausea) to 10 (appetite as good as can be, nausea as bad as can be), and each score was recorded separately.

  6. Short-term complications [Up to 30 days after operation.]

    Complications during the 30-day postoperative period

  7. Adverse events [Up to 30 days after operation.]

    Any adverse events possibly related to treatment with Foeniculum vulgare ironing.

  8. Hospitalization costs [During postoperative hospitalization, up to 30 days after operation.]

    Postoperative in-patients costs

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Age: 18 ~ 85 years old; sex is not limited.

  2. Selective operation of colorectal partial resection.

  3. Participants are volunteered to participate in this study, sign informed consent, and cooperated with follow-up.

Exclusion Criteria:
  1. Emergency surgery.

  2. Pregnant or lactating women.

  3. ASA class 4 or 5 patients.

  4. Patients with severe abdominal adhesions, which would cost more than 30 minutes to release. Patients with abdominal cocoon disease.

  5. Patients with peritoneal metastasis or inflammatory bowel disease.

  6. Patients undergoing enterostomy or total colectomy.

  7. Patients simultaneously enrolled in any other competing clinical study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Guoxue Road 37#,West China Hospital Chengdu Sichuan China 610041

Sponsors and Collaborators

  • West China Hospital

Investigators

  • Study Chair: Ziqiang Wang, MD, West China Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ziqiang Wang,MD, professor, West China Hospital
ClinicalTrials.gov Identifier:
NCT03711487
Other Study ID Numbers:
  • FV-GIR-2018
First Posted:
Oct 18, 2018
Last Update Posted:
Sep 17, 2019
Last Verified:
Jul 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ziqiang Wang,MD, professor, West China Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 17, 2019